Cardiol Therapeutics Inc Class A (CRDL) Financials

$1.98

$-0.31 (-13.35%)

As on 10-Sep-2026 16:26EDT

Market cap

$257 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

14.7

Div. Yield

0 %

Annual
Quarterly

Cashflow (CA$ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-23.85	-25.06	-25.18	-27.22	-23.55
Cash Flow from Investing Activities	--	-0.02	-0.02	-0.06	-0.07	-0.01
Cash from Financing Activities	--	15.54	18.84	-0.06	-0.05	93.44
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS (CA$)	-0.36	-0.34	-0.53	-0.32	-0.36	-0.44
Cash EPS (CA$)	--	-0.34	-0.52	-0.32	-0.35	-0.44
Adjusted Book Value (CA$)	--	0.18	0.35	0.43	0.60	1.34
Dividend per Share (CA$)	--	--	--	--	--	--
Cash Flow per Share (CA$)	--	-0.24	-0.36	-0.39	-0.43	-0.41
Free Cash Flow per Share (CA$)	--	-0.24	-0.36	-0.39	-0.43	-0.41

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-157.70	-137.61	-63.37	-39.71	-55.72
ROE (%)	-174.95	-158.75	-138.47	-63.58	-39.77	-55.89
ROA (%)	-117.13	-121.91	-106.99	-51.47	-34.15	-48.21
EBIT Margin (%)	--	--	--	--	--	-40,170.86
Net Margin (%)	--	--	--	--	--	-40,170.87
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	-1.00	-0.21
EBIT Growth (%)	20.06	7.79	-72.82	6.99	8.78	-54.39
Net Profit Growth (%)	-4.60	7.79	-72.82	6.99	8.78	-54.39
EPS Growth (%)	21.67	0.36	-0.62	0.09	0.19	0.11
Book Value Growth (%)	46.41	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.01	0.01	0.01	0.00	0.00
Short term debt to equity ratio	0.00	0.00	0.00	0.00	0.00	0.00
Current Ratio	5.55	4.16	4.52	4.36	6.27	7.53
Quick Ratio	5.55	--	--	4.39	--	7.51
Interest Coverage	--	--	--	--	--	--

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	105.58
Asset Turnover	--	--	--	--	--	0.00
Receivable days	--	--	--	--	--	837.83
Inventory Days	--	--	--	-545.53	763.37	729.47
Payable days	--	--	--	13,433.85	11,595.80	6,195.16
Cash Conversion Cycle	--	--	--	--	--	-4,627.86

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.